NCT05749848View on ClinicalTrials.gov

A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

February 24, 2023

Primary Completion Date

April 18, 2023

Study Completion Date

April 18, 2023

Conditions

Healthy

Interventions

DRUG

[¹⁴C]-LY3372689

Administered orally.

Trial Locations (1)

53704

LabCorp CRU, Inc., Madison

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY